Harmony Biosciences Holdings, Inc. ( NASDAQ:HRMY – Get Rating ) has been assigned an average rating of 'Moderate Buy' from the eleven research firms that are currently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $62.89. HRMY has been the topic of several research reports.

https://www.dailypolitical.com/2023/05/13/harmony-biosciences-holdings-inc-nasdaqhrmy-given-average-rating-of-moderate-buy-by-brokerages.html

#dailypolitical